Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGEN Repligen Corporation

交易中 07-22 15:06:56 EDT

128.31

+4.50

+3.63%

最高128.49	最低122.89	成交量26.58万
今开125.50	昨收123.81	日振幅4.52%
总市值71.69亿	流通市值66.77亿	总股本5,588万
成交额3,354万	换手率0.51%	流通股本5,204万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":128.31,"timestamp":1721675215220,"preClose":123.81,"halted":0,"volume":265834,"delay":0,"floatShares":52040393,"shares":55875894,"eps":0.264638,"marketStatus":"交易中","marketStatusCode":2,"change":4.5,"latestTime":"07-22 15:06:56 EDT","open":125.5,"high":128.49,"low":122.89,"amount":33543061.72032,"amplitude":0.045231,"askPrice":128.44,"askSize":18,"bidPrice":128.27,"bidSize":386,"shortable":3,"etf":0,"ttmEps":0.264638,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":123.81,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":123,"preClose":123.81,"latestTime":"08:00 EDT","volume":2,"amount":247.19,"timestamp":1721649602152},"postHourTrading":{"tag":"盘后","latestPrice":123.81,"preClose":123.81,"latestTime":"19:47 EDT","volume":23966,"amount":2967241.03,"timestamp":1721432848061},"volumeRatio":0.352932,"impliedVol":0.6673,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/RGEN","defaultTab":"news","newsList":[{"id":"2452432489","title":"Repligen Corporation盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452432489","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452432489?lang=zh_cn&edition=full","pubTime":"2024-07-19 00:46","pubTimestamp":1721321216,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日00时46分，Repligen Corporation股票出现异动，股价急速跳水5.06%。截至发稿，该股报125.62美元/股，成交量50.4579万股，换手率0.90%，振幅8.59%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.67%。其相关个股中，中进医疗、Avinger, Inc.、Predictive Oncology Inc.涨幅较大，Innovative Eyewear, Inc.、Sharps Technology Inc.、Innovative Eyewear Inc C/Wts 16/08/2027  Ser A较为活跃，换手率分别为31.27%、10.75%、2.81%，振幅较大的相关个股有Innovative Eyewear Inc C/Wts 16/08/2027  Ser A、Innovative Eyewear, Inc.、Sharps Technology Inc C/Wts ，振幅分别为56.15%、24.50%、21.48%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719004656af930122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719004656af930122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2452917842","title":"Repligen Corporation盘中异动 股价大涨5.16%报128.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452917842","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452917842?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:14","pubTimestamp":1721146474,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时14分，Repligen Corporation股票出现异动，股价快速拉升5.16%。截至发稿，该股报128.93美元/股，成交量16.1026万股，换手率0.29%，振幅4.65%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.02%。其相关个股中，AngioDynamics、中进医疗、美华国际涨幅较大，AngioDynamics、Innovative Eyewear, Inc.、Sharps Technology Inc.较为活跃，换手率分别为4.71%、3.71%、2.70%，振幅较大的相关个股有中进医疗、AngioDynamics、Milestone Scientific, Inc.，振幅分别为34.19%、15.84%、12.00%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717001434941f77c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717001434941f77c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2450136928","title":"Repligen Corporation盘中异动 早盘急速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450136928","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450136928?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:36","pubTimestamp":1720708581,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时36分，Repligen Corporation股票出现异动，股价急速拉升5.18%。截至发稿，该股报127.21美元/股，成交量9.6986万股，换手率0.17%，振幅4.19%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为1.07%。其相关个股中，Milestone Scientific, Inc.、Embecta Corp.、Biolife Solutions, Inc.涨幅较大，Innovative Eyewear, Inc.、Sharps Technology Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为9.50%、2.42%、1.14%，振幅较大的相关个股有Milestone Scientific, Inc.、Embecta Corp.、Biolife Solutions, Inc.，振幅分别为14.82%、12.33%、9.92%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112236229681c09b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112236229681c09b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2445049041","title":"美国研究综述-卡马斯、礼来、微策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2445049041","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445049041?lang=zh_cn&edition=full","pubTime":"2024-06-24 15:45","pubTimestamp":1719215146,"startTime":"0","endTime":"0","summary":"要闻             * Carmax Inc   ：加拿大皇家银行将其目标价从 73 美元上调至 75 美元             * 礼来   ：杰富瑞将目标价从994美元上调至1015美元             * 微策略公司  ：Canaccord Genuity将目标价从2047美元下调至1826美元             * Sharecare Inc   ：Canaccord Genuity将目标价从买入下调至持有             * 赛默飞世尔科技公司   ：加拿大皇家银行将目标价从662美元下调至660美元 以下是路透周一报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCTY","BK4578","LU0266512127.USD","FDS","LU0251142724.SGD","SRPT","BIO","SITC","RGEN","COCH","DAY","IE00B3S45H60.SGD","VLO","BK4579","IE00B1BXHZ80.USD","PSX","LU1551013342.USD","BK4588","LU0289739699.SGD","CYRX","BK4589","BK4587","LU0321505439.SGD","QDEL","LU1989771016.USD","PAYC","WKHS","T","LU1267930573.SGD","TMUS","WAL","LNG","MSTR","KMX","PYCR","MPC","KBH","DLR","VZ","IFF","BK4581","CYTK","SHCR","GILD","LLY","TMO","BK4585","IE00BJT1NW94.SGD","NVDA"],"gpt_icon":0},{"id":"2444212361","title":"Repligen Corporation盘中异动 早盘大幅跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444212361","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444212361?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:38","pubTimestamp":1718890704,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时38分，Repligen Corporation股票出现波动，股价大幅下跌5.24%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.45%。其相关个股中，Femasys Inc.、Precision Optics Corporation, Inc.、Infusystems Holdings, Inc.涨幅较大，Sharps Technology Inc.、Microbot Medical Inc.、Innovative Eyewear, Inc.较为活跃，换手率分别为2.08%、0.76%、0.44%，振幅较大的相关个股有Akoya Biosciences, Inc.、Repligen Corporation、Sharps Technology Inc.，振幅分别为4.20%、3.92%、3.10%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。消息层面，截至21时38分，《Guggenheim首予Repligen持有评级》资讯为影响Repligen Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213824968157df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213824968157df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2443680380","title":"BUZZ-Repligen公司长期首席执行官下台，股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2443680380","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443680380?lang=zh_cn&edition=full","pubTime":"2024-06-13 23:15","pubTimestamp":1718291726,"startTime":"0","endTime":"0","summary":" (更新)    6月13日 - ** 生物技术公司Repligen Corp   股价下跌9.9%，至128.76美元，为六个多月来最低价 ** 公司董事会同意首席执行官托尼-亨特从9月1日起转任执行董事长的计划** 2023 年加入 RGEN 担任总裁兼首席商务官的 Olivier Loeillot 将接替 Hunt 担任首席执行官 ** 亨特自2015年5月起担任RGEN首席执行官 ** Stephens分析师雅各布-约翰逊表示，这一宣布并不完全出人意料，尽管比预期的要早一些。** 包括盘中走势在内，该股今年累计下跌 28","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","RGEN","BK4121"],"gpt_icon":0},{"id":"2443768258","title":"BUZZ-Repligen因首席执行官交接而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2443768258","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443768258?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:35","pubTimestamp":1718289358,"startTime":"0","endTime":"0","summary":"    6月13日 - ** 生物技术公司 Repligen Corp    股价下跌 9.8% 至 128.83 美元 ** 公司称董事会已批准Tony Hunt从首席执行官转任执行董事长的计划，自9月1日起生效** 称董事会已任命2023年加入RGEN公司担任总裁兼首席商务官的Olivier Loeillot为首席执行官，接替Tony Hunt，同样从9月1日起生效。** 亨特自 2015 年 5 月起担任 RGEN 首席执行官 ** Stephens分析师雅各布-约翰逊说：\"这一宣布并不完全令人意外，尽管比预期的要早一些。** 包括盘中走势在内，该股今年累计下跌 28","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN","BK4121","BUZZ"],"gpt_icon":0},{"id":"2443689876","title":"Repligen Corporation盘中异动 早盘快速下跌7.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443689876","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443689876?lang=zh_cn&edition=full","pubTime":"2024-06-13 21:30","pubTimestamp":1718285453,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日21时30分，Repligen Corporation股票出现波动，股价快速跳水7.59%。截至发稿，该股报132.03美元/股，成交量3.3649万股，换手率0.06%，振幅0.00%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为1.29%。其相关个股中，Sharps Technology Inc C/Wts 、Sharps Technology Inc.、美华国际涨幅较大，Sharps Technology Inc.、Innovative Eyewear, Inc.、美华国际较为活跃，换手率分别为201.58%、19.50%、0.32%，振幅较大的相关个股有Sharps Technology Inc.、Predictive Oncology Inc.、Stevanato Group S.P.A.，振幅分别为4.44%、2.96%、1.84%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613213054aef4d3fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613213054aef4d3fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2434017275","title":"Repligen Corporation2024财年第一财季实现净利润2.09百万美元，同比减少92.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434017275","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434017275?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:23","pubTimestamp":1715271832,"startTime":"0","endTime":"0","summary":"3月31日，Repligen Corporation公布财报，公告显示公司2024财年第一财季净利润为2.09百万美元，同比减少92.75%；其中营业收入为1.51亿美元，同比减少17.49%，每股基本收益为0.04美元。从资产负债表来看，Repligen Corporation总负债8.79亿美元，其中短期债务79.26百万美元，资产负债比为3.25，流动比率为6.37。机构评级：截至2024年3月31日，当前有10家机构对Repligen Corporation目标价做出预测，其中目标均价为204.80美元，其中最低目标价为170.00美元，最高目标价为225.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100024048aed7b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100024048aed7b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2432953121","title":"Repligen Corporation盘中异动 临近收盘急速拉升5.00%报166.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432953121","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432953121?lang=zh_cn&edition=full","pubTime":"2024-05-03 03:57","pubTimestamp":1714679858,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日03时57分，Repligen Corporation股票出现异动，股价大幅拉升5.00%。截至发稿，该股报166.29美元/股，成交量69.0393万股，换手率1.24%，振幅6.82%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为1.32%。其相关个股中，Nexgel Inc C/Wts 01/12/2026 、Nyxoah Sa、Innovative Eyewear, Inc.涨幅较大，Predictive Oncology Inc.、AtriCure、登士柏较为活跃，换手率分别为9.63%、4.98%、2.66%，振幅较大的相关个股有Sharps Technology Inc.、Predictive Oncology Inc.、Innovative Eyewear, Inc.，振幅分别为32.06%、15.76%、14.18%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030357397a57f04a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030357397a57f04a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2432570203","title":"Repligen 公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570203","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432570203?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:52","pubTimestamp":1714571577,"startTime":"0","endTime":"0","summary":"   * Repligen Corp   公布的截至三月份的季度调整后每股收益为28美分，低于去年同期的每股收益64美分。12 位分析师对该季度的平均预期是每股收益 30 美分。华尔街预期为每股收益 27 美分至 34 美分。* Repligen 公司公布的本季度每股收益为 4 美分。* 公司报告的季度净收入为 209 万美元。* Repligen Corp本季度股价下跌了10.7%，今年迄今为止下跌了8.7%。华尔街对 Repligen 公司 12 个月目标价的中位数为 215.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2432770105","title":"Repligen Corporation盘中异动 早盘快速下跌6.18%报154.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432770105","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432770105?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:31","pubTimestamp":1714570282,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时31分，Repligen Corporation股票出现异动，股价大幅下挫6.18%。截至发稿，该股报154.06美元/股，成交量3.2838万股，换手率0.06%，振幅4.87%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.35%。其相关个股中，Predictive Oncology Inc.、Milestone Scientific, Inc.、Singular Genomics Systems, Inc.涨幅较大，Predictive Oncology Inc.、Repligen Corporation、Atrion较为活跃，换手率分别为76.81%、0.06%、0.05%，振幅较大的相关个股有Glucotrack, Inc.、Predictive Oncology Inc.、Repligen Corporation，振幅分别为7.79%、6.26%、4.87%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012131237a57db31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012131237a57db31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2431489912","title":"Repligen Corp    预计每股收益 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431489912","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431489912?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:33","pubTimestamp":1714404798,"startTime":"0","endTime":"0","summary":"   * Repligen公司   将于5月1日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆市的公司的营收将从去年同期的1.8266亿美元降至1.5062亿美元，降幅为17.8%。* LSEG分析师对Repligen公司的平均预期为每股收益30美分。* 华尔街对 Repligen Corp 的 12 个月目标价中位数为 215.00 美元，高于其上次收盘价 166.58 美元。4月29日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"gpt_icon":0},{"id":"2429190453","title":"Repligen Corporation盘中异动 急速拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429190453","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429190453?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879078,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时31分，Repligen Corporation股票出现异动，股价急速上涨5.44%。截至发稿，该股报166.05美元/股，成交量1.9061万股，换手率0.03%，振幅0.58%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.35%。其相关个股中，Repligen Corporation、Glucotrack, Inc.、AtriCure涨幅较大，Glucotrack, Inc.、Predictive Oncology Inc.、Microbot Medical Inc.较为活跃，换手率分别为0.10%、0.06%、0.06%，振幅较大的相关个股有AtriCure、Repligen Corporation、Staar Surgical Company，振幅分别为1.76%、1.53%、1.35%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232131188b4abe56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232131188b4abe56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2428359101","title":"Repligen Corporation盘中异动 早盘大幅跳水5.43%报152.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428359101","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428359101?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:31","pubTimestamp":1713447102,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时31分，Repligen Corporation股票出现异动，股价快速下挫5.43%。截至发稿，该股报152.24美元/股，成交量6.7003万股，换手率0.12%，振幅1.31%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.11%。其相关个股中，中进医疗、Nephros, Inc.、瑞思迈涨幅较大，Predictive Oncology Inc.、Repligen Corporation、Bionano Genomics, Inc.较为活跃，换手率分别为0.46%、0.12%、0.09%，振幅较大的相关个股有Bionano Genomics, Inc.、中进医疗、Repligen Corporation，振幅分别为4.90%、4.67%、1.83%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213142861e7108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213142861e7108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2422154694","title":"Repligen Corporation盘中异动 早盘大幅下挫5.00%报188.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422154694","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422154694?lang=zh_cn&edition=full","pubTime":"2024-03-25 22:23","pubTimestamp":1711376624,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日22时23分，Repligen Corporation股票出现波动，股价快速跳水5.00%。截至发稿，该股报188.13美元/股，成交量5.0263万股，换手率0.09%，振幅4.48%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.59%。其相关个股中，Nexgel Inc C/Wts 01/12/2026 、Sharps Technology Inc C/Wts 、Nexgel, Inc涨幅较大，Bionano Genomics, Inc.、Femasys Inc.、Atrion较为活跃，换手率分别为0.91%、0.55%、0.39%，振幅较大的相关个股有Nexgel Inc C/Wts 01/12/2026 、中进医疗、Innovative Eyewear, Inc.，振幅分别为28.20%、13.03%、10.46%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252223447a4eea90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252223447a4eea90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2421075928","title":"Repligen Corporation涨1.67% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2421075928","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421075928?lang=zh_cn&edition=full","pubTime":"2024-03-22 03:12","pubTimestamp":1711048354,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日03时12分，Repligen Corporation股票出现异动，股价急速上涨1.67%。截至发稿，该股报200.00美元/股，成交量13.4558万股，换手率0.24%，振幅1.68%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.97%。其相关个股中，Innovative Eyewear Inc C/Wts 16/08/2027  Ser A、美华国际、Nyxoah Sa涨幅较大，Sharps Technology Inc.、Femasys Inc.、Avinger, Inc.较为活跃，换手率分别为9.90%、3.90%、3.31%，振幅较大的相关个股有中进医疗、Innovative Eyewear Inc C/Wts 16/08/2027  Ser A、Innovative Eyewear, Inc.，振幅分别为36.76%、21.29%、17.21%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322031235861e02cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322031235861e02cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2417866057","title":"Repligen Corporation涨1.28% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2417866057","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417866057?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:31","pubTimestamp":1709908305,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时31分，Repligen Corporation股票出现异动，股价快速上涨1.28%。截至发稿，该股报201.00美元/股，成交量1.0032万股，换手率0.02%，振幅1.06%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.11%。其相关个股中，Predictive Oncology Inc.、Staar Surgical Company、Daxor Corporation涨幅较大，Avinger, Inc.、Predictive Oncology Inc.、Femasys Inc.较为活跃，换手率分别为2.69%、0.16%、0.15%，振幅较大的相关个股有Femasys Inc.、泰利福、Retractable Technologies, Inc.，振幅分别为2.95%、2.00%、1.64%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822314687e774fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822314687e774fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2414247701","title":"Repligen Corp2023财年实现净利润41.58百万美元，同比减少77.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414247701","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414247701?lang=zh_cn&edition=full","pubTime":"2024-02-25 00:21","pubTimestamp":1708791670,"startTime":"0","endTime":"0","summary":"12月31日，Repligen Corp公布财报，公告显示公司2023财年净利润为41.58百万美元，同比减少77.65%；其中营业收入为6.39亿美元，同比减少20.32%，每股基本收益为0.75美元。从资产负债表来看，Repligen Corp总负债8.53亿美元，其中短期债务75.08百万美元，资产负债比为3.32，流动比率为7.04。机构评级：截至2023年12月31日，当前有12家机构对Repligen Corp目标价做出预测，其中目标均价为206.65美元，其中最低目标价为160.00美元，最高目标价为230.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500211281b3133e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500211281b3133e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2413420708","title":"嗡嗡声--美国股票走势-Toll Brothers、Natgas 公司、Eton 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2413420708","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413420708?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:55","pubTimestamp":1708530942,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月21日 - 华尔街周三下跌，因为投资者在等待芯片设计公司英伟达的高风险财报，如果财报不尽如人意，可能会阻碍今年的人工智能热潮。美东时间10:33，道琼斯工业平均指数  下跌0.24%，报38472.83点。标准普尔500指数  下跌0.26%，报4,962.55点；纳斯达克综合指数  下跌0.62%，报15,533.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PANW","WING","NOVA","VRT","PLTR","BK4519","CRWD",".DJI","CYH","LU1804176565.USD","RGEN","AMZN","S","DOG","RUN","DXD","CNX","SDOW","CHK","IE00BJJMRX11.SGD","LU0130103400.USD","LU2249611893.SGD","LU1169590202.USD","LU1093756325.SGD","BK4535","DDM","ENPH","NVDA","SMCI","SPWR","FTNT","DJX",".SPX","UDOW","TOL","TDOC","EBS","COIN","CSGP","IEP","LUNR","SSTK","MARA","EQT","ETON",".IXIC","IFF","LU0079474960.USD","RIOT","IONS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":0.0066},{"period":"3month","weight":-0.2121},{"period":"6month","weight":-0.3045},{"period":"1year","weight":-0.2141},{"period":"ytd","weight":-0.3114}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约，并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品，这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验，公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究，弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外，公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.684211,"avgChangeRate":0.094555},{"month":2,"riseRate":0.421053,"avgChangeRate":0.031694},{"month":3,"riseRate":0.552632,"avgChangeRate":0.040702},{"month":4,"riseRate":0.473684,"avgChangeRate":-0.005601},{"month":5,"riseRate":0.564103,"avgChangeRate":0.050728},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.012809},{"month":7,"riseRate":0.487179,"avgChangeRate":0.022699},{"month":8,"riseRate":0.578947,"avgChangeRate":0.03293},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.040492},{"month":10,"riseRate":0.473684,"avgChangeRate":0.026608},{"month":11,"riseRate":0.447368,"avgChangeRate":0.027598},{"month":12,"riseRate":0.5,"avgChangeRate":-0.001659}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}